A project from the American Society of Retina Specialists
Sign in to view content
Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER
- Video
- Published 2018
Related
Category: Age-Related Macular Degeneration